<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2023-02-07T13:07:50Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4065049" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:4065049</identifier>
        <datestamp>2014-06-25</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-id journal-id-type="pmc">plosone</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC4065049</article-id>
              <article-id pub-id-type="pmcid">PMC4065049</article-id>
              <article-id pub-id-type="pmc-uid">4065049</article-id>
              <article-id pub-id-type="pmid">24949622</article-id>
              <article-id pub-id-type="pmid">24949622</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-14-08371</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0100773</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Internet-Delivered Cognitive Behavior Therapy for Adolescents with Obsessive-Compulsive Disorder: An Open Trial</article-title>
                <alt-title alt-title-type="running-head">Internet-Delivered CBT for Pediatric OCD</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lenhard</surname>
                    <given-names>Fabian</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1"/>
                  <xref ref-type="corresp" rid="cor1">
                    <sup>*</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Vigerland</surname>
                    <given-names>Sarah</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Andersson</surname>
                    <given-names>Erik</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rück</surname>
                    <given-names>Christian</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Mataix-Cols</surname>
                    <given-names>David</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Thulin</surname>
                    <given-names>Ulrika</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ljótsson</surname>
                    <given-names>Brjánn</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Serlachius</surname>
                    <given-names>Eva</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1"/>
                </contrib>
              </contrib-group>
              <aff id="aff1">
                <addr-line>Department of Clinical Neuroscience, Centre for Psychiatric Research and Education, Karolinska Institutet, Stockholm, Sweden</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Jiménez-Murcia</surname>
                    <given-names>Susana</given-names>
                  </name>
                  <role>Editor</role>
                  <xref ref-type="aff" rid="edit1"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>University Hospital of Bellvitge-IDIBELL; CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III; Department of Clinical Sciences, School of Medicine, University of Barcelona, Spain</addr-line>
              </aff>
              <author-notes>
                <corresp id="cor1">* E-mail: <email>fabian.lenhard@ki.se</email></corresp>
                <fn fn-type="COI-statement">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
                </fn>
                <fn fn-type="con">
                  <p>Conceived and designed the experiments: FL DMC ES CR EA. Performed the experiments: FL SV. Analyzed the data: FL DMC ES CR EA. Contributed reagents/materials/analysis tools: UT SV EA BL. Wrote the paper: FL DMC ES CR EA.</p>
                </fn>
              </author-notes>
              <pub-date pub-type="collection">
                <year>2014</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>20</day>
                <month>6</month>
                <year>2014</year>
              </pub-date>
              <volume>9</volume>
              <issue>6</issue>
              <elocation-id>e100773</elocation-id>
              <history>
                <date date-type="received">
                  <day>24</day>
                  <month>2</month>
                  <year>2014</year>
                </date>
                <date date-type="accepted">
                  <day>25</day>
                  <month>5</month>
                  <year>2014</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2014 Lenhard et al</copyright-statement>
                <copyright-year>2014</copyright-year>
                <copyright-holder>Lenhard et al</copyright-holder>
                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p>
                </license>
              </permissions>
              <abstract>
                <sec>
                  <title>Background</title>
                  <p>International guidelines recommend Cognitive Behavior Therapy (CBT) as the first line treatment for pediatric obsessive-compulsive disorder (OCD). However, a substantial proportion of patients do not have access to such treatment. We developed and tested the feasibility, efficacy and acceptability of a novel therapist-guided, Internet-delivered CBT (ICBT) platform for adolescents with OCD.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p>An interactive, age-appropriate ICBT platform (“BiP OCD”) was developed. Twenty-one adolescents (12–17 years) with a DSM-IV diagnosis of OCD and their parents were enrolled in the study. All participants received 12 weeks of ICBT with therapist support. The primary outcome measure was the Children’s Yale-Brown Obsessive-Compulsive Scale (CY-BOCS). Acceptability was assessed at post-treatment.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p>Participants completed on average 8.29 (<italic>SD</italic> = 3.0) of the 12 treatment chapters. Treatment yielded significant improvements on all clinician-, parent- and most self-administered outcome measures, with a large effect size of <italic>d</italic> = 2.29 (<italic>95% CI</italic> 1.5–3.07) on the CY-BOCS. Patients continued to improve at follow-up. At 6-month follow-up, 71% were classified as responders (≥35% decrease on the CY-BOCS) and 76% as being in remission (CY-BOCS score ≤12). Average clinician support time was less than 20 minutes per patient per week. The majority of participants felt that BiP OCD was age-appropriate and rated the treatment as good or very good.</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p>ICBT could be efficacious, acceptable, and cost-effective for adolescents with OCD. More rigorously controlled studies are needed to further evaluate the treatment.</p>
                </sec>
                <sec>
                  <title>Trial Registration</title>
                  <p>ClinicalTrials.gov; <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT01809990">NCT01809990</ext-link>.</p>
                </sec>
              </abstract>
              <funding-group>
                <funding-statement>Financial support was provided by Stockholm County Council and through the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet (PPG 20120167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
              </funding-group>
              <counts>
                <page-count count="11"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <sec id="s1">
              <title>Introduction</title>
              <p>Obsessive-compulsive disorder (OCD) is a potentially severe and often chronic mental disorder <xref rid="pone.0100773-American1" ref-type="bibr">[1]</xref> that affects up to 2% of children and adolescents <xref rid="pone.0100773-Flament1" ref-type="bibr">[2]</xref>, <xref rid="pone.0100773-ValleniBasile1" ref-type="bibr">[3]</xref>. Pediatric OCD is commonly associated with severe impairments in academic, social and family functioning <xref rid="pone.0100773-Piacentini1" ref-type="bibr">[4]</xref> and increases the risk of future OCD and other comorbid anxiety, mood, and eating disorders in adulthood <xref rid="pone.0100773-Wewetzer1" ref-type="bibr">[5]</xref>–<xref rid="pone.0100773-Micali1" ref-type="bibr">[7]</xref>. As duration of illness may predict long-term persistence of the disorder, early intervention is strongly advised <xref rid="pone.0100773-Micali2" ref-type="bibr">[8]</xref>.</p>
              <p>International guidelines recommend cognitive behavior therapy (CBT) as the first-line treatment for pediatric OCD <xref rid="pone.0100773-NICE1" ref-type="bibr">[9]</xref>, <xref rid="pone.0100773-American2" ref-type="bibr">[10]</xref>. Several meta-analyses have shown that CBT is an effective treatment for pediatric OCD <xref rid="pone.0100773-Reynolds1" ref-type="bibr">[11]</xref>–<xref rid="pone.0100773-Abramowitz1" ref-type="bibr">[13]</xref>, with average symptom reductions between 40 and 64% on the Children’s Yale-Brown Obsessive-Compulsive Scale <xref rid="pone.0100773-Scahill1" ref-type="bibr">[14]</xref>. Despite the existence of effective treatments, many OCD sufferers never seek help and, if they do, they seldom get access to good quality CBT <xref rid="pone.0100773-Schwartz1" ref-type="bibr">[15]</xref>, <xref rid="pone.0100773-Kohn1" ref-type="bibr">[16]</xref>. A lack of suitably trained therapists, psychosocial factors and geographical distances are frequent barriers to accessing such interventions <xref rid="pone.0100773-Valderhaug1" ref-type="bibr">[17]</xref>, <xref rid="pone.0100773-Goodwin1" ref-type="bibr">[18]</xref>.</p>
              <p>Internet-delivered CBT (ICBT) is one way of increasing both the accessibility to CBT and treatment capacity. ICBT often includes the same treatment content as regular CBT but entails much less therapist contact. Patients work on their own with web-based treatment material and homework assignments and therapist support is provided through emails and telephone calls. In a recent review of 108 studies, ICBT was found to be an effective and probably cost-effective intervention in the treatment of adults with various psychiatric disorders, with depression, anxiety disorders and chronic pain being the most studied conditions <xref rid="pone.0100773-Hedman1" ref-type="bibr">[19]</xref>. Furthermore, non-inferiority trials indicate that ICBT is at least as effective as traditional face-to-face CBT for depression, social anxiety disorder and panic disorder <xref rid="pone.0100773-Andersson1" ref-type="bibr">[20]</xref>–<xref rid="pone.0100773-Bergstrm1" ref-type="bibr">[22]</xref>. The efficacy of ICBT for adults with OCD has been demonstrated in two uncontrolled studies and two randomized waitlist-controlled trials, with large within-group as well as between-group effect sizes <xref rid="pone.0100773-Andersson2" ref-type="bibr">[23]</xref>–<xref rid="pone.0100773-Wootton2" ref-type="bibr">[26]</xref>.</p>
              <p>The development of internet-based treatments for children and adolescents with mental disorders lags considerably behind, despite a very high rate of Internet usage in this age group. For example, in Sweden, 90% of young people aged 12–24 years and 96% of school children aged 12–15 years have access to an Internet-connected computer on a daily basis, which makes them the most connected age group in the population <xref rid="pone.0100773-Findahl1" ref-type="bibr">[27]</xref>. To date, only a handful of case series and open trials <xref rid="pone.0100773-Richardson1" ref-type="bibr">[28]</xref>, <xref rid="pone.0100773-Vigerland1" ref-type="bibr">[29]</xref> and two randomized controlled studies of therapist-supported ICBT for pediatric anxiety disorders <xref rid="pone.0100773-Spence1" ref-type="bibr">[30]</xref>, <xref rid="pone.0100773-March1" ref-type="bibr">[31]</xref> have been conducted. To our knowledge, no ICBT protocols exist for pediatric OCD. The aims of this study were to develop and initially test the feasibility, efficacy and acceptability of a novel therapist-guided, ICBT platform for adolescents with OCD.</p>
            </sec>
            <sec sec-type="methods" id="s2">
              <title>Methods</title>
              <sec id="s2a">
                <title>Participants</title>
                <p>The protocol for this trial and supporting TREND checklist are available as supporting information; see <bold><xref ref-type="supplementary-material" rid="pone.0100773.s004">protocol S1</xref> and <xref ref-type="supplementary-material" rid="pone.0100773.s005">S2</xref></bold> and <bold><xref ref-type="supplementary-material" rid="pone.0100773.s003">Checklist S1</xref></bold>. The study was approved by the Regional Ethical Review Board in Stockholm, Sweden and registered at clinicaltrials.gov (identifier: NCT01809990). Participants were 21 adolescents with a primary diagnosis of OCD and at least one of their parents. Both parents were invited to participate, though one parent was assigned as the main contact person (76% mothers). The mean time from OCD onset to inclusion in this study was <italic>M</italic> = 3.87 years (<italic>SD</italic> = 2.64). Twenty percent of the participants were on a psychotropic medication and 9 of the 21 had received some form of psychological intervention prior to enrolment in the current study. About two thirds of participants had at least one additional comorbid psychiatric diagnosis besides OCD. <xref rid="pone-0100773-t001" ref-type="table"><bold>Table 1</bold></xref> gives more detailed information on the demographic and clinical characteristics of the sample.</p>
                <table-wrap id="pone-0100773-t001" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0100773.t001</object-id>
                  <label>Table 1</label>
                  <caption>
                    <title>Demographic and clinical characteristics of the study sample (<italic>N</italic> = 21).</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone-0100773-t001-1" xlink:href="pone.0100773.t001"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Variable<sup>a</sup>
</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>N</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">%</td>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Age (years)</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>M (SD)</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">14.4 (2.64)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">min – max</td>
                          <td align="left" rowspan="1" colspan="1">12.3–17.3</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Gender</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">Girls</td>
                          <td align="left" rowspan="1" colspan="1">13</td>
                          <td align="left" rowspan="1" colspan="1">61.9%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Boys</td>
                          <td align="left" rowspan="1" colspan="1">8</td>
                          <td align="left" rowspan="1" colspan="1">38.1%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Adolescent lives with</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">Mother</td>
                          <td align="left" rowspan="1" colspan="1">4</td>
                          <td align="left" rowspan="1" colspan="1">19%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Father</td>
                          <td align="left" rowspan="1" colspan="1">1</td>
                          <td align="left" rowspan="1" colspan="1">4.8%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Both parents</td>
                          <td align="left" rowspan="1" colspan="1">11</td>
                          <td align="left" rowspan="1" colspan="1">52.4%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Alternating</td>
                          <td align="left" rowspan="1" colspan="1">5</td>
                          <td align="left" rowspan="1" colspan="1">23.8%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Ethnicity mothers</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">Swedish</td>
                          <td align="left" rowspan="1" colspan="1">17</td>
                          <td align="left" rowspan="1" colspan="1">81%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Other European</td>
                          <td align="left" rowspan="1" colspan="1">4</td>
                          <td align="left" rowspan="1" colspan="1">19%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Ethnicity fathers</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">Swedish</td>
                          <td align="left" rowspan="1" colspan="1">19</td>
                          <td align="left" rowspan="1" colspan="1">90.5%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Other European</td>
                          <td align="left" rowspan="1" colspan="1">1</td>
                          <td align="left" rowspan="1" colspan="1">4.8%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Middle East</td>
                          <td align="left" rowspan="1" colspan="1">1</td>
                          <td align="left" rowspan="1" colspan="1">4.8%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Ethnicity adolescents</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">Swedish</td>
                          <td align="left" rowspan="1" colspan="1">20</td>
                          <td align="left" rowspan="1" colspan="1">95.2%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Other European</td>
                          <td align="left" rowspan="1" colspan="1">1</td>
                          <td align="left" rowspan="1" colspan="1">4.8%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Education father</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">Primary</td>
                          <td align="left" rowspan="1" colspan="1">3</td>
                          <td align="left" rowspan="1" colspan="1">14.3%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Secondary</td>
                          <td align="left" rowspan="1" colspan="1">7</td>
                          <td align="left" rowspan="1" colspan="1">33.3%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">University</td>
                          <td align="left" rowspan="1" colspan="1">11</td>
                          <td align="left" rowspan="1" colspan="1">52.4%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Education mother</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">Primary</td>
                          <td align="left" rowspan="1" colspan="1">0</td>
                          <td align="left" rowspan="1" colspan="1">0%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Secondary</td>
                          <td align="left" rowspan="1" colspan="1">4</td>
                          <td align="left" rowspan="1" colspan="1">19%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">University</td>
                          <td align="left" rowspan="1" colspan="1">17</td>
                          <td align="left" rowspan="1" colspan="1">81%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Current psychotropic medication</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">None</td>
                          <td align="left" rowspan="1" colspan="1">17</td>
                          <td align="left" rowspan="1" colspan="1">81%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Methylphenidate</td>
                          <td align="left" rowspan="1" colspan="1">3</td>
                          <td align="left" rowspan="1" colspan="1">14.3%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Antiepileptic</td>
                          <td align="left" rowspan="1" colspan="1">1</td>
                          <td align="left" rowspan="1" colspan="1">4.8%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Earlier psychological treatments</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">None</td>
                          <td align="left" rowspan="1" colspan="1">12</td>
                          <td align="left" rowspan="1" colspan="1">57.1%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Unspecified</td>
                          <td align="left" rowspan="1" colspan="1">6</td>
                          <td align="left" rowspan="1" colspan="1">28.6%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">CBT (without ERP)</td>
                          <td align="left" rowspan="1" colspan="1">2</td>
                          <td align="left" rowspan="1" colspan="1">9.5%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">CBT (with ERP)</td>
                          <td align="left" rowspan="1" colspan="1">1</td>
                          <td align="left" rowspan="1" colspan="1">4.8%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Frequency of comorbid diagnoses</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">Specific phobia</td>
                          <td align="left" rowspan="1" colspan="1">8</td>
                          <td align="left" rowspan="1" colspan="1">38.1%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">GAD</td>
                          <td align="left" rowspan="1" colspan="1">7</td>
                          <td align="left" rowspan="1" colspan="1">33.3%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">ADHD</td>
                          <td align="left" rowspan="1" colspan="1">5</td>
                          <td align="left" rowspan="1" colspan="1">23.8%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Separation anx.</td>
                          <td align="left" rowspan="1" colspan="1">3</td>
                          <td align="left" rowspan="1" colspan="1">14.3%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Social phobia</td>
                          <td align="left" rowspan="1" colspan="1">3</td>
                          <td align="left" rowspan="1" colspan="1">14.3%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Depression</td>
                          <td align="left" rowspan="1" colspan="1">2</td>
                          <td align="left" rowspan="1" colspan="1">9.5%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Conduct disorder</td>
                          <td align="left" rowspan="1" colspan="1">1</td>
                          <td align="left" rowspan="1" colspan="1">4.8%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Number of participants with 0–4 comorbid diagnoses</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">None</td>
                          <td align="left" rowspan="1" colspan="1">6</td>
                          <td align="left" rowspan="1" colspan="1">28.6%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">One</td>
                          <td align="left" rowspan="1" colspan="1">5</td>
                          <td align="left" rowspan="1" colspan="1">23.8%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Two</td>
                          <td align="left" rowspan="1" colspan="1">7</td>
                          <td align="left" rowspan="1" colspan="1">33.3%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Three</td>
                          <td align="left" rowspan="1" colspan="1">2</td>
                          <td align="left" rowspan="1" colspan="1">9.5%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Four</td>
                          <td align="left" rowspan="1" colspan="1">1</td>
                          <td align="left" rowspan="1" colspan="1">4.8%</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Duration of OCD</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>M (SD)</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">3.87 (2.64)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Min – max</td>
                          <td align="left" rowspan="1" colspan="1">0.5–10.4</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="nt101">
                      <label/>
                      <p><italic>Note</italic><sup>a</sup>Abbreviations: CBT = Cognitive Behavior Therapy, ERP = Exposure and response prevention, GAD = Generalized anxiety disorder, ADHD = Attention deficit hyperactivity disorder, Separation anx = Separation anxiety disorder.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>Written, informed consent was obtained from all participating adolescents and parents prior to inclusion. Inclusion criteria were: a) a primary DSM-IV-TR diagnosis of OCD, b) a total score of ≥16 on the Children’s Yale-Brown Obsessive-Compulsive Scale (CY-BOCS <xref rid="pone.0100773-Scahill1" ref-type="bibr">[14]</xref>), c) age between 12 and 17 years, d) ability to read and write Swedish, e) daily access to the Internet, f) a parent that was able to co-participate in the treatment, and g) participants on psychotropic medication must had been on a stable dose for the last 6 weeks prior to baseline assessment. Exclusion criteria were: h) diagnosed autism spectrum disorder, psychosis, bipolar disorder, severe eating disorder, i) suicidal ideation, j) on-going substance dependence, k) not able to read or understand the basics of the ICBT self-help material, l) to have completed a course of CBT for OCD within last 12 months (defined as at least 5 sessions CBT including exposure and response prevention), and m) on-going psychological treatment for OCD or another anxiety disorder.</p>
              </sec>
              <sec id="s2b">
                <title>Measures</title>
                <sec id="s2b1">
                  <title>Primary outcome measure</title>
                  <p>Children’s Yale-Brown Obsessive-Compulsive Scale (CY-BOCS, <xref rid="pone.0100773-Scahill1" ref-type="bibr">[14]</xref>), a semi-structured clinician administered interview for assessment of symptom severity in pediatric OCD.</p>
                </sec>
                <sec id="s2b2">
                  <title>Secondary outcome measures</title>
                  <p>Children’s Obsessional Compulsive Inventory Revised (ChOCI-R <xref rid="pone.0100773-Shafran1" ref-type="bibr">[32]</xref>), a self- and parent-report measure of OCD symptom severity. ChOCI-R provides an impairment subscale that is comparable to the CY-BOCS total score (analogous items and scale range between 0–40). Child Obsessive-Compulsive Impact Scale – Revised (COIS-R <xref rid="pone.0100773-Piacentini2" ref-type="bibr">[33]</xref>), a self- and parent-report scale of OCD symptom impact on everyday life. Clinical Global Impression – Severity (CGI- S <xref rid="pone.0100773-National1" ref-type="bibr">[34]</xref>), a brief clinician rating of symptom severity. Clinical Global Impression - Improvement (CGI-I <xref rid="pone.0100773-Guy1" ref-type="bibr">[35]</xref>), a brief clinician rating of the patients’ symptom severity change relative to the baseline assessment. Children’s Global Assessment Scale (CGAS <xref rid="pone.0100773-Shaffer1" ref-type="bibr">[36]</xref>) is an instrument to quantify the overall level of functioning in children and adolescents. Spence Child Anxiety Scale – Child and Parent version (SCAS C/P <xref rid="pone.0100773-Spence2" ref-type="bibr">[37]</xref>), a child and parent self-report measure of anxiety. Child Depression Inventory (CDI-S, <xref rid="pone.0100773-Kovacs1" ref-type="bibr">[38]</xref>), a short version of the CDI, measuring levels of depression in young people. Strengths and Difficulties Questionnaire (SDQ <xref rid="pone.0100773-Goodman1" ref-type="bibr">[39]</xref>), a self- and parent-report measure of general mental health. Family Accommodation Scale, Parent-Report (FAS-PR <xref rid="pone.0100773-Flessner1" ref-type="bibr">[40]</xref>), a parent-report questionnaire focusing on accommodation behaviors in parents with a child with OCD.</p>
                </sec>
                <sec id="s2b3">
                  <title>Treatment acceptability</title>
                  <p>At post-treatment, participants answered questions about the acceptability and experience of ICBT, such as “Usually you visit a clinic to meet with a psychologist. In this Internet treatment you had contact with your psychologist via mail and telephone. How did that work for you?” (multiple choice answers, e.g. “I would have preferred to meet my psychologist face-to-face more often.”) and “Which grade do you give this Internet treatment as a whole?” (from “bad” to “very good”).</p>
                  <p>All self- and parent-rated measures were administered online, a method which has been shown to be reliable and to produce results similar to traditional paper-and-pencil administration <xref rid="pone.0100773-Hedman3" ref-type="bibr">[41]</xref>.</p>
                </sec>
              </sec>
              <sec id="s2c">
                <title>Procedure</title>
                <p>Based on power calculations, we aimed to enroll 21 participants in the trial (assuming a large effect size, Coheńs <italic>d</italic> = 0.8, 80% power, <italic>p</italic> = .05). Participants were recruited from January to February 2013 in the Stockholm area through newspaper and Internet advertisements. Information about the study was given on the research group’s homepage at the Child and Adolescent Mental Health Service in Stockholm (<ext-link ext-link-type="uri" xlink:href="http://www.bup.se/bip">www.bup.se/bip</ext-link>). Recruitment was carried out in two steps: telephone screening and face-to-face assessment. <xref ref-type="fig" rid="pone-0100773-g001"><bold>Figure 1</bold></xref> provides an overview of the inclusion, assessment points and treatment procedures.</p>
                <fig id="pone-0100773-g001" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0100773.g001</object-id>
                  <label>Figure 1</label>
                  <caption>
                    <title>Study flow chart.</title>
                  </caption>
                  <graphic xlink:href="pone.0100773.g001"/>
                </fig>
                <p>Applicants registered their interest to participate on the study’s homepage. A clinical psychologist then contacted applicants for an initial telephone interview in order to assess broad inclusion and exclusion criteria. Following this telephone screening, potential participants and their parents were invited to a face-to-face assessments, which included the diagnostic screening interview MINI-KID <xref rid="pone.0100773-SheehanD1" ref-type="bibr">[42]</xref>. Once the diagnosis of OCD was confirmed, the adolescents and their parents were jointly interview with the CY-BOCS. Clinicians administered CGI-I, CGI-S and C-GAS in connection with the interview. Both MINI-KID and CY-BOCS interviews were conducted by experienced clinical psychologists or a final-year clinical psychology student. To assure the reliability of the assessments, pre- and post-treatment CY-BOCS interviews were taped and a random sample (<italic>N</italic> = 19, 45%) of anonymised interviews were rated by two independent evaluators (FL or SV). Inter-class correlations for CY-BOCS inter-rater reliability was <italic>r = .</italic>92, which is excellent according to statistical guidelines <xref rid="pone.0100773-Shrout1" ref-type="bibr">[43]</xref>. Following face-to-face assessment, participants meeting inclusion criteria were provided with an information sheet and verbal information on the study as well as consent form. Included participants were then asked to fill in self-report measures on the Internet.</p>
                <p>At post-treatment, and no later than 4 weeks after the treatment had ended, families were asked to complete all self-administered measures over the Internet and were invited back to our clinic where all clinical interviews were re-administered (CY-BOCS, CGI-I, CGI-S and C-GAS). At 3- and 6-month follow-up, the same measures were administered over the telephone.</p>
              </sec>
              <sec id="s2d">
                <title>Intervention</title>
                <p>The ICBT treatment platform, named “BiP [BarnInternetProjektet] OCD” is completely web-based and designed for use by both adolescents with OCD and their parents. The technical platform is especially designed with age-appropriate appearance, animations and interactive scripts, and was previously tested in an open trial of ICBT for specific phobias in children <xref rid="pone.0100773-Vigerland1" ref-type="bibr">[29]</xref>. The OCD treatment manual was constructed by the research group and consists of evidence-based interventions adapted from other widely researched and validated protocols <xref rid="pone.0100773-Barrett1" ref-type="bibr">[44]</xref>–<xref rid="pone.0100773-Ivarsson1" ref-type="bibr">[50]</xref>. BiP OCD contains 12 chapters designed for the adolescent participants and 5 chapters designed for the parents. The content includes educative texts, films, and exercises. The parent protocol consists of 5 chapters that parallel the adolescent’s part of the treatment and address specific parent-related topics, such as family accommodation and parental coping strategies. BiP OCD is currently available in Swedish and an English version is being prepared. <xref rid="pone-0100773-t002" ref-type="table"><bold>Table 2</bold></xref> gives an overview of the structure and content of the treatment. Screenshots of some of the relevant sections are provided in <xref ref-type="fig" rid="pone-0100773-g002"><bold>Figure 2</bold></xref> and <bold><xref ref-type="supplementary-material" rid="pone.0100773.s001">Figure S1</xref> and <xref ref-type="supplementary-material" rid="pone.0100773.s002">S2</xref></bold>.</p>
                <fig id="pone-0100773-g002" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0100773.g002</object-id>
                  <label>Figure 2</label>
                  <caption>
                    <title>Screenshot of an animated psychoeducation film from BiP OCD (Chapter 1).</title>
                  </caption>
                  <graphic xlink:href="pone.0100773.g002"/>
                </fig>
                <table-wrap id="pone-0100773-t002" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0100773.t002</object-id>
                  <label>Table 2</label>
                  <caption>
                    <title>An overview of the content of the ICBT treatment protocol.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone-0100773-t002-2" xlink:href="pone.0100773.t002"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Treatment phase</td>
                          <td align="left" rowspan="1" colspan="1">Chapter</td>
                          <td align="left" rowspan="1" colspan="1">Parent chapters</td>
                          <td align="left" rowspan="1" colspan="1">Adolescent chapters</td>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Psychoeducation</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">1</td>
                          <td align="left" rowspan="1" colspan="1">Introduction to ICBT</td>
                          <td align="left" rowspan="1" colspan="1">Introduction to ICBT</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">2</td>
                          <td align="left" rowspan="1" colspan="1">About OCD</td>
                          <td align="left" rowspan="1" colspan="1">What is OCD?</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">3</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">We are cracking the code: The OCD circle</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">4</td>
                          <td align="left" rowspan="1" colspan="1">Exposure and response prevention</td>
                          <td align="left" rowspan="1" colspan="1">Building a hierarchy</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Exposure with response prevention (ERP)</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">5</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Testing exposure</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">6</td>
                          <td align="left" rowspan="1" colspan="1">Being an exposure coach</td>
                          <td align="left" rowspan="1" colspan="1">Planning your ERP training</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">7</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">New steps with ERP</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">8</td>
                          <td align="left" rowspan="1" colspan="1">When the family has OCD</td>
                          <td align="left" rowspan="1" colspan="1">ERP – frequent problems and solutions</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">9</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">More new steps with ERP</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">10</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Talking back to OCD - Coping with obsessions</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Relapse prevention</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">11</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">The final sprint</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">12</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Your treatment in the rear-view mirror</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
                <p>During the 12-week treatment period, the therapists had regular contact with participants in order to guide them through the treatment, choose homework assignments and problem-solve when necessary. Participants were instructed to initiate contact with the therapists by sending messages via the ICBT platform whenever they had questions or wanted to discuss any aspects of the treatment. In the case of inactivity of a participant (defined as either no log-ins, no completed assignments or no completed chapters for over one week), the therapist then initiated contact with the family by sending a message via the ICBT platform or directly calling the adolescent or parent. We measured the weekly amount of therapist time spent with each family. Therapist support was given by two licensed clinical psychologists experienced in the treatment of pediatric OCD (FL and SV) and a final year psychology student. Clinicians met once a week for supervision.</p>
              </sec>
              <sec id="s2e">
                <title>Statistical Analysis</title>
                <p>The statistical analyses were planned in advance and carried out with SPSS version 21 (SPSS inc., Chicago) and STATA version 13 (StataCorp Inc.). Hypothesis testing on the primary outcome pre−/post-treatment mean difference was done using two-sided paired t-tests, where no missing data occurred. At 3-month follow-up, there was a single subject with missing CY-BOCS scores; this missing value was replaced by multiple imputation. The imputation model included all longitudinal outcome measures. Ten data sets were generated. Results of identical analyses performed on each of the 10 data sets were combined following Rubin’s rules <xref rid="pone.0100773-Rubin1" ref-type="bibr">[51]</xref>.</p>
                <p>Because there were missing data at more than two time points on the secondary outcome variables, linear mixed effects models were implemented for analysis. The models included fixed effects for time (pre-, post-treatment, follow-up), and a random effect for individual subjects. Prior to analysis with mixed effects models the data was checked for the “missing at random” assumption. No significant differences could be found between participants with and without missing data on any baseline characteristics. Moreover, the data was checked for the modeĺs assumption of normally distributed residual errors, showing that our data met this assumption. Ordinal variables were analyzed using Wilcoxon signed ranks test. McNemar test was used for repeated binary variables. Effect sizes on primary and secondary outcomes are reported as Cohen’s <italic>d</italic> = (M<sub>1</sub>– M<sub>2</sub>)/SD<sub>pooled</sub> with 95% confidence intervals. We defined treatment response as a decrease of ≥35% on the CY-BOCS and remission as a CY-BOCS total score ≤12 <xref rid="pone.0100773-Farris1" ref-type="bibr">[52]</xref>.</p>
              </sec>
            </sec>
            <sec id="s3">
              <title>Results</title>
              <sec id="s3a">
                <title>Adherence</title>
                <p>Adolescents completed on average 8.29 (<italic>SD</italic> = 3.0) of the 12 treatment chapters. Parents completed on average 4.67 (SD = 0.79) of the five parent chapters. Non-completers were defined as adolescents completing fewer than 4 chapters, as chapters 1–4 provide basic psychoeducation and tools for exposure and response prevention. One adolescent did not reach chapter 4, though a closer examination of that case revealed that the participant had understood the rationale and worked successfully with exposure and response prevention despite not logging onto the system. Therefore, we considered that all participants had partaken in the treatment.</p>
              </sec>
              <sec id="s3b">
                <title>Primary Outcome Results</title>
                <p>Means and standard deviations for all outcome measures at four assessments points are presented in <xref rid="pone-0100773-t003" ref-type="table"><bold>Table 3</bold></xref> and effect sizes in <xref rid="pone-0100773-t004" ref-type="table"><bold>Table 4</bold></xref>. There was a significant decrease of OCD symptom severity assessed by the CY-BOCS from pre- to post-treatment with <italic>t</italic>(20) = 6.135, <italic>p</italic>&lt;.001 resulting in a large effect size of <italic>d</italic> = 2.29 (<italic>95% CI</italic> 1.5–3.07). The average reduction in CY-BOCS total score from pre to post-treatment was 40.8% (<italic>SD</italic> = 25.35).</p>
                <table-wrap id="pone-0100773-t003" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0100773.t003</object-id>
                  <label>Table 3</label>
                  <caption>
                    <title>Outcome measures’ means (<italic>M</italic>) and standard deviations (<italic>SD</italic>) at pre-, post-treatment and follow-up<sup>a</sup>.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone-0100773-t003-3" xlink:href="pone.0100773.t003"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>Measures</italic>
                            <xref ref-type="table-fn" rid="nt103">b</xref>
                          </td>
                          <td colspan="2" align="left" rowspan="1">pre</td>
                          <td colspan="2" align="left" rowspan="1">post</td>
                          <td colspan="2" align="left" rowspan="1">3-month FU</td>
                          <td colspan="2" align="left" rowspan="1">6-month FU</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>Clinician-rated</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>M</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>SD</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>M</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>SD</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>M</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>SD</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>M</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>SD</italic>
                          </td>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CY-BOCS</td>
                          <td align="left" rowspan="1" colspan="1">21.33</td>
                          <td align="left" rowspan="1" colspan="1">3.54</td>
                          <td align="left" rowspan="1" colspan="1">12.05**</td>
                          <td align="left" rowspan="1" colspan="1">4.51</td>
                          <td align="left" rowspan="1" colspan="1">8.8**</td>
                          <td align="left" rowspan="1" colspan="1">5.11</td>
                          <td align="left" rowspan="1" colspan="1">9.14</td>
                          <td align="left" rowspan="1" colspan="1">6.41</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">C-GAS</td>
                          <td align="left" rowspan="1" colspan="1">56.1</td>
                          <td align="left" rowspan="1" colspan="1">6.28</td>
                          <td align="left" rowspan="1" colspan="1">71.5**</td>
                          <td align="left" rowspan="1" colspan="1">9.32</td>
                          <td align="left" rowspan="1" colspan="1">73.95</td>
                          <td align="left" rowspan="1" colspan="1">8.99</td>
                          <td align="left" rowspan="1" colspan="1">73.48</td>
                          <td align="left" rowspan="1" colspan="1">9.69</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>Self-rated</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ChOCI-R symptom</td>
                          <td align="left" rowspan="1" colspan="1">13.57</td>
                          <td align="left" rowspan="1" colspan="1">8.71</td>
                          <td align="left" rowspan="1" colspan="1">6.43**</td>
                          <td align="left" rowspan="1" colspan="1">6.6</td>
                          <td align="left" rowspan="1" colspan="1">5.31</td>
                          <td align="left" rowspan="1" colspan="1">6.74</td>
                          <td align="left" rowspan="1" colspan="1">5.00</td>
                          <td align="left" rowspan="1" colspan="1">6.61</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ChOCI-R impairment</td>
                          <td align="left" rowspan="1" colspan="1">22.57</td>
                          <td align="left" rowspan="1" colspan="1">8.08</td>
                          <td align="left" rowspan="1" colspan="1">11.62**</td>
                          <td align="left" rowspan="1" colspan="1">6.34</td>
                          <td align="left" rowspan="1" colspan="1">9.88</td>
                          <td align="left" rowspan="1" colspan="1">8.87</td>
                          <td align="left" rowspan="1" colspan="1">10.38</td>
                          <td align="left" rowspan="1" colspan="1">9.09</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">COIS-R</td>
                          <td align="left" rowspan="1" colspan="1">17.33</td>
                          <td align="left" rowspan="1" colspan="1">15.49</td>
                          <td align="left" rowspan="1" colspan="1">6.57**</td>
                          <td align="left" rowspan="1" colspan="1">7.9</td>
                          <td align="left" rowspan="1" colspan="1">5.19</td>
                          <td align="left" rowspan="1" colspan="1">8.38</td>
                          <td align="left" rowspan="1" colspan="1">6.00</td>
                          <td align="left" rowspan="1" colspan="1">8.99</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SCAS OCD subscale</td>
                          <td align="left" rowspan="1" colspan="1">9.05</td>
                          <td align="left" rowspan="1" colspan="1">4.96</td>
                          <td align="left" rowspan="1" colspan="1">4.05**</td>
                          <td align="left" rowspan="1" colspan="1">3.41</td>
                          <td align="left" rowspan="1" colspan="1">2.88</td>
                          <td align="left" rowspan="1" colspan="1">3.76</td>
                          <td align="left" rowspan="1" colspan="1">3.25</td>
                          <td align="left" rowspan="1" colspan="1">3.98</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SCAS without OCD</td>
                          <td align="left" rowspan="1" colspan="1">30.43</td>
                          <td align="left" rowspan="1" colspan="1">16.91</td>
                          <td align="left" rowspan="1" colspan="1">20.24**</td>
                          <td align="left" rowspan="1" colspan="1">13.54</td>
                          <td align="left" rowspan="1" colspan="1">18.94</td>
                          <td align="left" rowspan="1" colspan="1">14.01</td>
                          <td align="left" rowspan="1" colspan="1">18.25</td>
                          <td align="left" rowspan="1" colspan="1">14.24</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CDI-S</td>
                          <td align="left" rowspan="1" colspan="1">9.62</td>
                          <td align="left" rowspan="1" colspan="1">1.4</td>
                          <td align="left" rowspan="1" colspan="1">9.86</td>
                          <td align="left" rowspan="1" colspan="1">1.15</td>
                          <td align="left" rowspan="1" colspan="1">2.5**</td>
                          <td align="left" rowspan="1" colspan="1">2.73</td>
                          <td align="left" rowspan="1" colspan="1">2.19</td>
                          <td align="left" rowspan="1" colspan="1">2.14</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SDQ</td>
                          <td align="left" rowspan="1" colspan="1">13.52</td>
                          <td align="left" rowspan="1" colspan="1">5.52</td>
                          <td align="left" rowspan="1" colspan="1">10.57</td>
                          <td align="left" rowspan="1" colspan="1">4.02</td>
                          <td align="left" rowspan="1" colspan="1">10.69</td>
                          <td align="left" rowspan="1" colspan="1">4.22</td>
                          <td align="left" rowspan="1" colspan="1">10.50</td>
                          <td align="left" rowspan="1" colspan="1">4.84</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>Parent-rated</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>ChOCI-R symptom</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">12.35</td>
                          <td align="left" rowspan="1" colspan="1">6.76</td>
                          <td align="left" rowspan="1" colspan="1">6.50**</td>
                          <td align="left" rowspan="1" colspan="1">5.07</td>
                          <td align="left" rowspan="1" colspan="1">5.26</td>
                          <td align="left" rowspan="1" colspan="1">5.58</td>
                          <td align="left" rowspan="1" colspan="1">4.53</td>
                          <td align="left" rowspan="1" colspan="1">4.33</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>ChOCI-R impairment</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">24.90</td>
                          <td align="left" rowspan="1" colspan="1">7.03</td>
                          <td align="left" rowspan="1" colspan="1">17.8**</td>
                          <td align="left" rowspan="1" colspan="1">9.95</td>
                          <td align="left" rowspan="1" colspan="1">12.37*</td>
                          <td align="left" rowspan="1" colspan="1">8.1</td>
                          <td align="left" rowspan="1" colspan="1">11.47</td>
                          <td align="left" rowspan="1" colspan="1">6.41</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">COIS-R</td>
                          <td align="left" rowspan="1" colspan="1">25.25</td>
                          <td align="left" rowspan="1" colspan="1">16.09</td>
                          <td align="left" rowspan="1" colspan="1">16.75*</td>
                          <td align="left" rowspan="1" colspan="1">17.15</td>
                          <td align="left" rowspan="1" colspan="1">13.00</td>
                          <td align="left" rowspan="1" colspan="1">15.65</td>
                          <td align="left" rowspan="1" colspan="1">13.88</td>
                          <td align="left" rowspan="1" colspan="1">15.02</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">FAS-PR</td>
                          <td align="left" rowspan="1" colspan="1">14.60</td>
                          <td align="left" rowspan="1" colspan="1">8.44</td>
                          <td align="left" rowspan="1" colspan="1">9.60*</td>
                          <td align="left" rowspan="1" colspan="1">7.09</td>
                          <td align="left" rowspan="1" colspan="1">6.89</td>
                          <td align="left" rowspan="1" colspan="1">8.05</td>
                          <td align="left" rowspan="1" colspan="1">6.47</td>
                          <td align="left" rowspan="1" colspan="1">6.91</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SCAS OCD subscale</td>
                          <td align="left" rowspan="1" colspan="1">7.33</td>
                          <td align="left" rowspan="1" colspan="1">4.22</td>
                          <td align="left" rowspan="1" colspan="1">4.25*</td>
                          <td align="left" rowspan="1" colspan="1">3.24</td>
                          <td align="left" rowspan="1" colspan="1">3.16</td>
                          <td align="left" rowspan="1" colspan="1">3.1</td>
                          <td align="left" rowspan="1" colspan="1">2.76</td>
                          <td align="left" rowspan="1" colspan="1">3.01</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SCAS without OCD</td>
                          <td align="left" rowspan="1" colspan="1">25.24</td>
                          <td align="left" rowspan="1" colspan="1">15.73</td>
                          <td align="left" rowspan="1" colspan="1">16.00**</td>
                          <td align="left" rowspan="1" colspan="1">13.54</td>
                          <td align="left" rowspan="1" colspan="1">16.37</td>
                          <td align="left" rowspan="1" colspan="1">12.24</td>
                          <td align="left" rowspan="1" colspan="1">15.65</td>
                          <td align="left" rowspan="1" colspan="1">14.13</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SDQ</td>
                          <td align="left" rowspan="1" colspan="1">12.0</td>
                          <td align="left" rowspan="1" colspan="1">6.71</td>
                          <td align="left" rowspan="1" colspan="1">10.3</td>
                          <td align="left" rowspan="1" colspan="1">6.34</td>
                          <td align="left" rowspan="1" colspan="1">10.32</td>
                          <td align="left" rowspan="1" colspan="1">6.63</td>
                          <td align="left" rowspan="1" colspan="1">9.65</td>
                          <td align="left" rowspan="1" colspan="1">6.44</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="nt102">
                      <label/>
                      <p><italic>Note</italic><sup>a</sup>Uncorrected means and standard deviations,</p>
                    </fn>
                    <fn id="nt103">
                      <label>b</label>
                      <p>Abbreviations: CY-BOCS = Children Yale-Brown Obsessive Compulsive Scale, C-GAS = Children’s Global Assessment Scale, ChOCI-R symptom/impairment = Children’s Obsessive Compulsive Inventory Revised symptom and impairment scales, COIS-R = Child Obsessive-Compulsive Impairment Scale Revised, SCAS = Spence Child Anxiety Scale, CDI-S = Children’s Depression Inventory – Short version, FAS-PR = Family Accommodation Scale Parent Rating, SDQ = Strength and Difficulties Questionnaire. *p&lt;.05; **p&lt;.001, p values refer to comparisons from pre-treatment to post, post-treatment to 3-month follow-up, and 3-month follow-up to 6-month follow-up, respectively.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <table-wrap id="pone-0100773-t004" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0100773.t004</object-id>
                  <label>Table 4</label>
                  <caption>
                    <title>Outcome measures’ effect sizes, <italic>ES</italic> (Cohen’s <italic>d</italic>) at pre-, post-treatment and follow-up.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone-0100773-t004-4" xlink:href="pone.0100773.t004"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>Measures</italic>
                            <sup>a</sup>
                          </td>
                          <td colspan="2" align="left" rowspan="1">pre/post</td>
                          <td colspan="2" align="left" rowspan="1">post/3-month FU</td>
                          <td colspan="2" align="left" rowspan="1">3-month FU/6-month FU</td>
                          <td colspan="2" align="left" rowspan="1">pre/6-month FU</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>Clinician-rated</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>ES</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>(95% CI)</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>ES</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>(95% CI)</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>ES</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>(95% CI)</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>ES</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>(95% CI)</italic>
                          </td>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CY-BOCS</td>
                          <td align="left" rowspan="1" colspan="1">2.29</td>
                          <td align="left" rowspan="1" colspan="1">(1.50–3.07)</td>
                          <td align="left" rowspan="1" colspan="1">0.67</td>
                          <td align="left" rowspan="1" colspan="1">(0.04–1.3)</td>
                          <td align="left" rowspan="1" colspan="1">0.05</td>
                          <td align="left" rowspan="1" colspan="1">(−0.56–0.66)</td>
                          <td align="left" rowspan="1" colspan="1">2.35</td>
                          <td align="left" rowspan="1" colspan="1">(1.50–3.18)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">C-GAS</td>
                          <td align="left" rowspan="1" colspan="1">−1.94</td>
                          <td align="left" rowspan="1" colspan="1">(−2.60–−1.12)</td>
                          <td align="left" rowspan="1" colspan="1">−0.27</td>
                          <td align="left" rowspan="1" colspan="1">(−0.93–0.30)</td>
                          <td align="left" rowspan="1" colspan="1">−0.06</td>
                          <td align="left" rowspan="1" colspan="1">(−0.67–0.55)</td>
                          <td align="left" rowspan="1" colspan="1">−2.12</td>
                          <td align="left" rowspan="1" colspan="1">(−2.90–−1.32)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>Self-rated</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ChOCI-R symptom</td>
                          <td align="left" rowspan="1" colspan="1">0.92</td>
                          <td align="left" rowspan="1" colspan="1">(0.28–1.56)</td>
                          <td align="left" rowspan="1" colspan="1">0.17</td>
                          <td align="left" rowspan="1" colspan="1">(−0.49–0.82)</td>
                          <td align="left" rowspan="1" colspan="1">0.05</td>
                          <td align="left" rowspan="1" colspan="1">(−0.65–0.74)</td>
                          <td align="left" rowspan="1" colspan="1">1.09</td>
                          <td align="left" rowspan="1" colspan="1">(0.38–1.78)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ChOCI-R impairment</td>
                          <td align="left" rowspan="1" colspan="1">1.51</td>
                          <td align="left" rowspan="1" colspan="1">(0.81–2.18)</td>
                          <td align="left" rowspan="1" colspan="1">0.23</td>
                          <td align="left" rowspan="1" colspan="1">(−0.42–0.88)</td>
                          <td align="left" rowspan="1" colspan="1">−0.06</td>
                          <td align="left" rowspan="1" colspan="1">(−0.75–0.64)</td>
                          <td align="left" rowspan="1" colspan="1">1.43</td>
                          <td align="left" rowspan="1" colspan="1">(0.68–2.16)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">COIS-R</td>
                          <td align="left" rowspan="1" colspan="1">0.88</td>
                          <td align="left" rowspan="1" colspan="1">(0.24–1.50)</td>
                          <td align="left" rowspan="1" colspan="1">0.17</td>
                          <td align="left" rowspan="1" colspan="1">(−0.48–0.82)</td>
                          <td align="left" rowspan="1" colspan="1">−0.09</td>
                          <td align="left" rowspan="1" colspan="1">(−0.79–0.60)</td>
                          <td align="left" rowspan="1" colspan="1">0.86</td>
                          <td align="left" rowspan="1" colspan="1">(0.18–1.54)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SCAS OCD subscale</td>
                          <td align="left" rowspan="1" colspan="1">1.17</td>
                          <td align="left" rowspan="1" colspan="1">(0.51–1.83)</td>
                          <td align="left" rowspan="1" colspan="1">0.33</td>
                          <td align="left" rowspan="1" colspan="1">(−0.33–0.98)</td>
                          <td align="left" rowspan="1" colspan="1">−0.10</td>
                          <td align="left" rowspan="1" colspan="1">(−0.79–0.60)</td>
                          <td align="left" rowspan="1" colspan="1">1.27</td>
                          <td align="left" rowspan="1" colspan="1">(.55–1.98)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SCAS without OCD</td>
                          <td align="left" rowspan="1" colspan="1">0.67</td>
                          <td align="left" rowspan="1" colspan="1">(0.04–1.28)</td>
                          <td align="left" rowspan="1" colspan="1">0.09</td>
                          <td align="left" rowspan="1" colspan="1">(−0.56–0.74)</td>
                          <td align="left" rowspan="1" colspan="1">0.05</td>
                          <td align="left" rowspan="1" colspan="1">(−0.64–0.74)</td>
                          <td align="left" rowspan="1" colspan="1">0.77</td>
                          <td align="left" rowspan="1" colspan="1">(0.09–1.44)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CDI-S</td>
                          <td align="left" rowspan="1" colspan="1">−0.19</td>
                          <td align="left" rowspan="1" colspan="1">(−0.79–0.42)</td>
                          <td align="left" rowspan="1" colspan="1">3.7</td>
                          <td align="left" rowspan="1" colspan="1">(2.61–4.77)</td>
                          <td align="left" rowspan="1" colspan="1">0.13</td>
                          <td align="left" rowspan="1" colspan="1">(−0.57–0.82)</td>
                          <td align="left" rowspan="1" colspan="1">4.24</td>
                          <td align="left" rowspan="1" colspan="1">(2.88–5.58)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SDQ</td>
                          <td align="left" rowspan="1" colspan="1">0.61</td>
                          <td align="left" rowspan="1" colspan="1">(−0.01–1.23)</td>
                          <td align="left" rowspan="1" colspan="1">−0.03</td>
                          <td align="left" rowspan="1" colspan="1">(−0.68–0.62)</td>
                          <td align="left" rowspan="1" colspan="1">0.04</td>
                          <td align="left" rowspan="1" colspan="1">(−0.65–0.73)</td>
                          <td align="left" rowspan="1" colspan="1">0.58</td>
                          <td align="left" rowspan="1" colspan="1">(0.09–1.24)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>Parent-rated</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>ChOCI-R symptom</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.94</td>
                          <td align="left" rowspan="1" colspan="1">(0.29–1.58)</td>
                          <td align="left" rowspan="1" colspan="1">0.23</td>
                          <td align="left" rowspan="1" colspan="1">(−0.4–0.86)</td>
                          <td align="left" rowspan="1" colspan="1">0.15</td>
                          <td align="left" rowspan="1" colspan="1">(−0.51–0.80)</td>
                          <td align="left" rowspan="1" colspan="1">1.31</td>
                          <td align="left" rowspan="1" colspan="1">(0.59–2.01)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>ChOCI-R impairment</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.79</td>
                          <td align="left" rowspan="1" colspan="1">(0.15–1.42)</td>
                          <td align="left" rowspan="1" colspan="1">0.60</td>
                          <td align="left" rowspan="1" colspan="1">(−0.05–1.24)</td>
                          <td align="left" rowspan="1" colspan="1">0.12</td>
                          <td align="left" rowspan="1" colspan="1">(−0.53–0.78)</td>
                          <td align="left" rowspan="1" colspan="1">1.94</td>
                          <td align="left" rowspan="1" colspan="1">(1.15–2.71)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">COIS-R</td>
                          <td align="left" rowspan="1" colspan="1">0.45</td>
                          <td align="left" rowspan="1" colspan="1">(−0.17–1.07)</td>
                          <td align="left" rowspan="1" colspan="1">0.23</td>
                          <td align="left" rowspan="1" colspan="1">(−0.4–0.86)</td>
                          <td align="left" rowspan="1" colspan="1">−0.06</td>
                          <td align="left" rowspan="1" colspan="1">(−0.71–0.60)</td>
                          <td align="left" rowspan="1" colspan="1">0.67</td>
                          <td align="left" rowspan="1" colspan="1">(0.00–1.32)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">FAS-PR</td>
                          <td align="left" rowspan="1" colspan="1">0.60</td>
                          <td align="left" rowspan="1" colspan="1">(−0.03–1.22)</td>
                          <td align="left" rowspan="1" colspan="1">0.36</td>
                          <td align="left" rowspan="1" colspan="1">(−0.28–0.99)</td>
                          <td align="left" rowspan="1" colspan="1">0.06</td>
                          <td align="left" rowspan="1" colspan="1">(−0.60–0.71)</td>
                          <td align="left" rowspan="1" colspan="1">1.00</td>
                          <td align="left" rowspan="1" colspan="1">(0.31–1.67)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SCAS OCD subscale</td>
                          <td align="left" rowspan="1" colspan="1">0.82</td>
                          <td align="left" rowspan="1" colspan="1">(0.17–1.45)</td>
                          <td align="left" rowspan="1" colspan="1">0.34</td>
                          <td align="left" rowspan="1" colspan="1">(−0.29–0.97)</td>
                          <td align="left" rowspan="1" colspan="1">0.13</td>
                          <td align="left" rowspan="1" colspan="1">(−0.53–0.78)</td>
                          <td align="left" rowspan="1" colspan="1">1.22</td>
                          <td align="left" rowspan="1" colspan="1">(0.52–1.92)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SCAS without OCD</td>
                          <td align="left" rowspan="1" colspan="1">0.63</td>
                          <td align="left" rowspan="1" colspan="1">(0.0–1.25)</td>
                          <td align="left" rowspan="1" colspan="1">−0.03</td>
                          <td align="left" rowspan="1" colspan="1">(−0.66–0.59)</td>
                          <td align="left" rowspan="1" colspan="1">0.05</td>
                          <td align="left" rowspan="1" colspan="1">(−0.60–0.71)</td>
                          <td align="left" rowspan="1" colspan="1">0.64</td>
                          <td align="left" rowspan="1" colspan="1">(−0.02–1.29)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SDQ</td>
                          <td align="left" rowspan="1" colspan="1">0.29</td>
                          <td align="left" rowspan="1" colspan="1">(−0.33–0.91)</td>
                          <td align="left" rowspan="1" colspan="1">0.0</td>
                          <td align="left" rowspan="1" colspan="1">(−0.63–0.63)</td>
                          <td align="left" rowspan="1" colspan="1">0.10</td>
                          <td align="left" rowspan="1" colspan="1">(−0.55–0.76)</td>
                          <td align="left" rowspan="1" colspan="1">0.39</td>
                          <td align="left" rowspan="1" colspan="1">(−0.26–1.03)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="nt104">
                      <label/>
                      <p><italic>Note</italic><sup>a</sup>Abbreviations: CY-BOCS = Children Yale-Brown Obsessive Compulsive Scale, C-GAS = Children’s Global Assessment Scale, ChOCI-R symptom/impairment = Children’s Obsessive Compulsive Inventory Revised symptom and impairment scales, COIS-R = Child Obsessive-Compulsive Impairment Scale Revised, SCAS = Spence Child Anxiety Scale, CDI-S = Children’s Depression Inventory – Short version, FAS-PR = Family Accommodation Scale Parent Rating, SDQ = Strength and Difficulties Questionnaire.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>Twelve participants (57%, <italic>95% CI</italic> 37–76%) responded to the treatment (symptom decrease of ≥35% on the CY-BOCS). Ten participants (48%, <italic>95% CI</italic> 28–68%) had a CY-BOCS score ≤12 at post-treatment and were classed as being in remission.</p>
              </sec>
              <sec id="s3c">
                <title>Secondary Outcome Results</title>
                <p>The mean difference in clinician-rated symptom severity (CGI-S) from pre- to post-treatment was 1.8 points (<italic>SD</italic> = 1.50), representing a statistically significant improvement (<italic>Z = </italic>−3.412, <italic>p</italic>&lt;.01). Eleven participants (52%, <italic>95% CI</italic> 32–72%) were rated as “much improved” or “very much improved” on the CGI-I. All self- and parent-rated measures of OCD symptom severity and impairment as well as family accommodation improved significantly with moderate to large effect sizes (<italic>d</italic> = 0.45–1.51). No significant improvements were observed on CDI-S (depression) and SDQ (general mental health).</p>
              </sec>
              <sec id="s3d">
                <title>Follow-up Results</title>
                <p>There was a further significant decrease on the CY-BOCS from post-treatment to 3-month follow-up (<italic>Z</italic> = −3.63; <italic>p</italic>&lt;.001) with a moderate effect size indicating that patients continued to improve over this time period. At 6 months no further significant changes on CY-BOCS occurred. 71% (<italic>95% CI</italic> 50–86%) of participants were classed as responders both at 3 and 6 months (defined as decrease of ≥35% on the CY-BOCS). The average symptom reduction on the CY-BOCS total score from pre-treatment to 3-months follow-up was 56.6% (<italic>SD</italic> = 26.52) and from pre-treatment to 6- months follow-up 55.0% (<italic>SD</italic> = 32.23). At the 3-month follow-up 62% (<italic>95% CI</italic> 41–79%) of the patients were in remission (CY-BOCS score of ≤12), whereas 76% (<italic>95% CI</italic> 55–89%) of the patients were in remission at 6-month follow-up.</p>
                <p>There were also significant severity changes from post-treatment to 3-month follow-up on the clinician-rated CGI-S (<italic>Z</italic> =  −2.653, <italic>p</italic> = .008) and a non-significant trend for the CGI-I (<italic>Z</italic> = −1.941, <italic>p = </italic>.052). CGI-S and CGI-I scores did not change significantly from 3- to 6-month follow-up. The mean difference from pre-treatment to 6-month follow-up on the CGI-S was 2.35 points (<italic>SD = </italic>1.37). At 3 and 6 months, 71% (<italic>95% CI</italic> 50–86%) of participants were rated as “much improved” or “very much improved” on the CGI-I. No further significant changes from post-treatment to follow-up occurred on self- or parent-rated secondary outcome measures, except for a decrease in parent-rated ChOCI-R impairment and a decrease in self-rated CDI-S at 3 months (see <xref rid="pone-0100773-t003" ref-type="table"><bold>Table 3</bold></xref> and <xref rid="pone-0100773-t004" ref-type="table"><bold>4</bold></xref> for details). <xref ref-type="fig" rid="pone-0100773-g003"><bold>Figure 3</bold></xref> displays means on clinician rated CY-BOCS scores and the corresponding self- and parent-rated ChOCI-R impairment subscales.</p>
                <fig id="pone-0100773-g003" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0100773.g003</object-id>
                  <label>Figure 3</label>
                  <caption>
                    <title>Mean CY-BOCS and adolescent- respective parent-rated ChOCI-R impairment subscale scores at pre-treatment, post-treatment and follow-up.</title>
                  </caption>
                  <graphic xlink:href="pone.0100773.g003"/>
                </fig>
              </sec>
              <sec id="s3e">
                <title>Amount of Clinician Support</title>
                <p>The average total clinician time per participant (including e-mails and telephone calls to both adolescents and parents) was 233.8 minutes (<italic>SD</italic> = 153.7), which equals to 19.5 minutes per week and participant.</p>
              </sec>
              <sec id="s3f">
                <title>Treatment Acceptability</title>
                <p>Overall, all 21 participants rated the treatment as “good” or “very good”. Nineteen of 21 participants found the treatment age-appropriate. Seventeen of 21 felt comfortable with working only via Internet without meeting the clinician face-to-face, whereas 4 participants would have preferred occasional face-to-face contact with the clinician, in addition to ICBT. An individual analysis of these 4 cases did not indicate any difference in treatment outcome with 3 of the 4 being responders.</p>
              </sec>
            </sec>
            <sec id="s4">
              <title>Discussion</title>
              <p>We tested the efficacy and acceptability of a novel Internet-delivered CBT (ICBT) platform for adolescents with OCD and their primary caregivers. BiP OCD uniquely combines available evidence-based techniques with age-appropriate interactive materials, films, and animations, making it particularly suitable for this age group.</p>
              <p>The participants experienced a significant decrease of OCD symptom severity as well as in OCD-related impairment at post-treatment. Moreover, the treatment had beneficial effects on comorbid anxiety levels and general functioning. In addition, we observed a delayed effect on comorbid levels of depression at 3-month follow-up, a finding that could be interpreted as a secondary effect of reduced OCD symptom impact on everyday functioning. Clinician-rated, self-rated as well as parent-rated measures coherently showed moderate to large within group effect sizes. Furthermore, treatment effects on OCD severity and other secondary measures continued throughout the follow-up period, indicating the sustained benefits of the intervention. The program was consistently rated as age-appropriate and all participating families rated the treatment as being good or very good overall. The majority of participants also felt comfortable working on the Internet with brief telephone and online therapist support.</p>
              <p>Interestingly, the correspondence between clinician (CY-BOCS) and adolescent self-ratings (ChOCI-R) of OCD severity in our study was better than the correspondence between adolescent self-ratings and parent ratings. Similarly, we observed a discrepancy between the adolescent self-ratings and parent ratings of OCD impact on everyday life functioning (COIS-R). In both cases, parents provided higher ratings, indicating higher symptom severity and poorer everyday life functioning, though the clinician, self- and parent ratings tended to converge at the 6-month follow-up. In our experience, parents sometimes have limited insight on the occurrence and impact of some OCD symptoms, particularly obsessions of potentially embarrassing content.</p>
              <sec id="s4a">
                <title>Limitations</title>
                <p>This open trial is limited by the absence of a control condition. Consequently, it was not possible to effectively blind participants or assessors and to control for non-specific factors such as expectancy, effects of assessments or clinician contact. Yet, prior research shows that independent evaluators and non-blinded treating clinicians have a high level of agreement in global ratings of OCD symptom improvement <xref rid="pone.0100773-Lewin1" ref-type="bibr">[53]</xref>. Moreover, considering the high rates of chronicity in OCD <xref rid="pone.0100773-Skoog1" ref-type="bibr">[54]</xref>, <xref rid="pone.0100773-Visser1" ref-type="bibr">[55]</xref>, the response and remission rates observed in this study are unlikely to be caused by spontaneous remission. Nevertheless, the results should be considered preliminary until a controlled trial is conducted with blind assessments and, ideally, with a credible control condition. Second, by recruiting participants via media and newspapers, we may have introduced important selection biases; the high rates of university degrees in the parents indicate that the sample represents a selected socio-economic group. Thus, although the participants had substantial levels of OCD symptom severity, impairment and comorbid diagnoses, this may have been a particularly motivated group and therefore the generalizability of the results to routine clinical settings remains to be established. Third, the sample consisted mainly of moderately severe cases of OCD and therefore the findings may not generalize to more severe or complex cases. Finally, a longer follow-up of the patients would be helpful to establish the durability of the treatment outcomes reported here.</p>
              </sec>
              <sec id="s4b">
                <title>Future Directions</title>
                <p>The magnitude of ICBT treatment effect on the primary outcome measure (CY-BOCS) was comparable to that of previous studies of standard face-to-face CBT for OCD <xref rid="pone.0100773-Barrett1" ref-type="bibr">[44]</xref>–<xref rid="pone.0100773-The1" ref-type="bibr">[48]</xref>. Crucially, the average therapist time spent on supporting patients through ICBT (on average 19.5 minutes per week and participant) was approximately one third of the time usually spent in standard CBT. Therefore, ICBT could potentially be a cost-effective intervention for adolescents with OCD, as it has been shown in many adult ICBT studies in other behavioral and psychiatric problems <xref rid="pone.0100773-Hedman1" ref-type="bibr">[19]</xref>. An important research question for the future will be how much therapist support is required to achieve optimal cost-effectiveness without impairing efficacy. The literature suggests that the total absence of therapist support is likely to lead to high drop out rates and poorer treatment outcomes <xref rid="pone.0100773-MataixCols1" ref-type="bibr">[56]</xref>. Moreover, it has been shown that proactively scheduled therapist phone support is associated with enhanced treatment adherence and better outcomes, when compared to patient-requested telephone calls in computer-aided self-help for adults with OCD <xref rid="pone.0100773-Kenwright1" ref-type="bibr">[57]</xref>. Future trials manipulating the amount of clinician support could provide valuable information in this regard. Other central questions for the future are the identification of the patient groups that are more likely to benefit from ICBT and how this treatment modality could be used to complement and streamline regular clinical care for OCD.</p>
                <p>Possible further development of ICBT may involve the combination of web-based ICBT with integrated smartphone applications. Many everyday activities, such as Internet banking, social media or training applications, are currently both web- and smartphone-based. Smartphone applications have the potential to enhance certain aspects of web-based ICBT. For example, such an application could prompt the patient to engage in exposure and response prevention homework between sessions, thus potentially increasing adherence and overall outcomes <xref rid="pone.0100773-Simpson1" ref-type="bibr">[58]</xref>. A small number of studies have evaluated smartphone as the solitary format of treatment delivery <xref rid="pone.0100773-Donker1" ref-type="bibr">[59]</xref>, underlining the potential of smartphone applications as an extension of ICBT. Another promising add-on to ICBT would be videoteleconferencing and web-camera approaches, as a way to deliver face-to-face CBT to patients living in remote areas <xref rid="pone.0100773-Comer1" ref-type="bibr">[60]</xref>, <xref rid="pone.0100773-Storch1" ref-type="bibr">[61]</xref>.</p>
                <p>Finally, it will be important to study how to best utilize internet-delivered interventions in relation to face-to-face interventions. Considering the potential cost and time savings associated with ICBT, such interventions could perhaps be employed in a stepped-care manner, with ICBT as a first-line intervention and face-to-face CBT given to patients with more severe OCD or higher complexity <xref rid="pone.0100773-MataixCols2" ref-type="bibr">[62]</xref>, <xref rid="pone.0100773-Salloum1" ref-type="bibr">[63]</xref>. Intuitively, this could lead to a better distribution of scarce health care resources, with better access to standardized evidence-based treatment in primary and secondary care settings, and freeing more therapist resources for those in need of more highly specialized care. A different healthcare model may be to employ ICBT as an add-on or complement to standard CBT <xref rid="pone.0100773-Timpano1" ref-type="bibr">[64]</xref>. Future studies manipulating the sequence of ICBT and face-to-face CBT and incorporating a health-economic component are needed to evaluate these important questions.</p>
              </sec>
              <sec id="s4c">
                <title>Conclusion</title>
                <p>BiP OCD is a therapist-guided, internet-delivered CBT program designed for use by both adolescents with OCD and their parents or primary caregivers. ICBT requires only a fraction of therapist support, compared to standard face-to-face CBT. If the encouraging results of this open trial were replicated in more rigorously controlled studies, in relation to active control conditions and in routine clinical settings, ICBT could greatly increase the availability of effective psychological treatments for adolescents with OCD.</p>
              </sec>
            </sec>
            <sec sec-type="supplementary-material" id="s5">
              <title>Supporting Information</title>
              <supplementary-material content-type="local-data" id="pone.0100773.s001">
                <label>Figure S1</label>
                <caption>
                  <p>
                    <bold>Screenshot from BiP OCD - The OCD cycle (Chapter 2).</bold>
                  </p>
                  <p>(TIFF)</p>
                </caption>
                <media xlink:href="pone.0100773.s001.tiff">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0100773.s002">
                <label>Figure S2</label>
                <caption>
                  <p>
                    <bold>Screenshot from BiP OCD - Exercise on CBT and patient-therapist conversation (Chapter 4).</bold>
                  </p>
                  <p>(TIFF)</p>
                </caption>
                <media xlink:href="pone.0100773.s002.tiff">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0100773.s003">
                <label>Checklist S1</label>
                <caption>
                  <p>
                    <bold>TREND checklist.</bold>
                  </p>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0100773.s003.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0100773.s004">
                <label>Protocol S1</label>
                <caption>
                  <p>
                    <bold>Trial Protocol (Swedish).</bold>
                  </p>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0100773.s004.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0100773.s005">
                <label>Protocol S2</label>
                <caption>
                  <p>
                    <bold>Trial Protocol (English).</bold>
                  </p>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0100773.s005.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>We thank the participating adolescents and their parents, Mari Ljungström, trainee psychologist, for administrative assistance, Gunnar Dagnå for support in IT-communication solutions, Dr Kayoko Isomura for assistance in the statistical analyses.</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="pone.0100773-American1">
                <label>1</label>
                <mixed-citation publication-type="other">American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). APA.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Flament1">
                <label>2</label>
                <mixed-citation publication-type="other">Flament MF, Whitaker A, Rapoport JL, Davies M, Berg CZ, <etal>et al</etal>. (1988) Obsessive compulsive disorder in adolescence: an epidemiological study. J Am Acad Child Adolesc Psychiatry 27: 764–771. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/3264280">http://www.ncbi.nlm.nih.gov/pubmed/3264280</ext-link>. Accessed 30 May 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-ValleniBasile1">
                <label>3</label>
                <mixed-citation publication-type="other">Valleni-Basile LA, Garrison CZ, Jackson KL, Waller JL, McKeown RE, <etal>et al</etal>. (1994) Frequency of obsessive-compulsive disorder in a community sample of young adolescents. J Am Acad Child Adolesc Psychiatry 33: 782–791. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/8083134">http://www.ncbi.nlm.nih.gov/pubmed/8083134</ext-link> Accessed 30 May 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Piacentini1">
                <label>4</label>
                <mixed-citation publication-type="other">Piacentini J, Bergman RL, Keller M, McCracken J (2003) Functional impairment in children and adolescents with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 13 Suppl 1: S61-9. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/12880501">http://www.ncbi.nlm.nih.gov/pubmed/12880501</ext-link> Accessed 10 November 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Wewetzer1">
                <label>5</label>
                <mixed-citation publication-type="other">Wewetzer C, Jans T, Müller B, Neudörfl A, Bücherl U, <etal>et al</etal>. (2001) Long-term outcome and prognosis of obsessive-compulsive disorder with onset in childhood or adolescence. Eur Child Adolesc Psychiatry 10: 37–46. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/11315534">http://www.ncbi.nlm.nih.gov/pubmed/11315534</ext-link> Accessed 30 May 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Fullana1">
                <label>6</label>
                <mixed-citation publication-type="other">Fullana MA, Mataix-Cols D, Caspi A, Harrington H, Grisham JR, <etal>et al</etal>. (2009) Obsessions and compulsions in the community: prevalence, interference, help-seeking, developmental stability, and co-occurring psychiatric conditions. Am J Psychiatry 166: 329–336. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/19188283">http://www.ncbi.nlm.nih.gov/pubmed/19188283</ext-link> Accessed 21 December 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Micali1">
                <label>7</label>
                <mixed-citation publication-type="other">Micali N, Hilton K, Natatani E, Heyman I, Turner C, <etal>et al</etal>. (2011) Is childhood OCD a risk factor for eating disorders later in life? A longitudinal study. Psychol Med 41: 2507–2513. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/21733209">http://www.ncbi.nlm.nih.gov/pubmed/21733209</ext-link> Accessed 19 November 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Micali2">
                <label>8</label>
                <mixed-citation publication-type="other">Micali N, Heyman I, Perez M, Hilton K, Nakatani E, <etal>et al</etal>. (2010) Long-term outcomes of obsessive-compulsive disorder: follow-up of 142 children and adolescents. Br J Psychiatry 197: 128–134. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/20679265">http://www.ncbi.nlm.nih.gov/pubmed/20679265</ext-link> Accessed 26 August 2011.</mixed-citation>
              </ref>
              <ref id="pone.0100773-NICE1">
                <label>9</label>
                <mixed-citation publication-type="other">NICE (2006) Obsessive-compulsive disorder: Core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK56458/Accessed">http://www.ncbi.nlm.nih.gov/books/NBK56458/Accessed</ext-link> 18 December 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-American2">
                <label>10</label>
                <mixed-citation publication-type="other">American Psychiatric Association (2007) Practice guideline for the treatment of patients with obsessive-compulsive disorder. Arlington, VA: American Psychiatric Association. Available: <ext-link ext-link-type="uri" xlink:href="http://www.psychiatryonline.com">http://www.psychiatryonline.com</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Reynolds1">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Reynolds</surname><given-names>S</given-names></name>, <name><surname>Wilson</surname><given-names>C</given-names></name>, <name><surname>Austin</surname><given-names>J</given-names></name>, <name><surname>Hooper</surname><given-names>L</given-names></name> (<year>2012</year>) <article-title>Clinical Psychology Review Effects of psychotherapy for anxiety in children and adolescents?: A meta-analytic review</article-title>. <source>Clin Psychol Rev</source>
<volume>32</volume>: <fpage>251</fpage>–<lpage>262</lpage> Available: <pub-id pub-id-type="doi">10.1016/j.cpr.2012.01.005</pub-id>.<pub-id pub-id-type="pmid">22459788</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0100773-Watson1">
                <label>12</label>
                <mixed-citation publication-type="other">Watson HJ, Rees CS (2008) Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder. J Child Psychol Psychiatry 49: 489–498. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/18400058">http://www.ncbi.nlm.nih.gov/pubmed/18400058</ext-link> Accessed 23 November 2011.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Abramowitz1">
                <label>13</label>
                <mixed-citation publication-type="other">Abramowitz J, Whiteside S, Deacon B (2006) The effectiveness of treatment for pediatric obsessive-compulsive disorder: A meta-analysis. Behav Ther 36: 55–63. Available: <ext-link ext-link-type="uri" xlink:href="http://www.sciencedirect.com/science/article/pii/S0005789405800541">http://www.sciencedirect.com/science/article/pii/S0005789405800541</ext-link> Accessed 18 November 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Scahill1">
                <label>14</label>
                <mixed-citation publication-type="other">Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, <etal>et al</etal>. (1997) Children’s Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 36: 844–852. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/9183141">http://www.ncbi.nlm.nih.gov/pubmed/9183141</ext-link> Accessed 6 December 2011.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Schwartz1">
                <label>15</label>
                <mixed-citation publication-type="other">Schwartz C, Schlegl S, Katrin Kuelz A, Voderholzer U (2013) Treatment-seeking in OCD community cases and psychological treatment actually provided to treatment-seeking patients: A systematic review. J Obsessive Compuls Relat Disord. Available: <ext-link ext-link-type="uri" xlink:href="http://www.sciencedirect.com/science/article/pii/S2211364913000730">http://www.sciencedirect.com/science/article/pii/S2211364913000730</ext-link> Accessed 1 November 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Kohn1">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Kohn</surname><given-names>R</given-names></name>, <name><surname>Saxena</surname><given-names>S</given-names></name>, <name><surname>Levav</surname><given-names>I</given-names></name>, <name><surname>Saraceno</surname><given-names>B</given-names></name> (<year>2004</year>) <article-title>The treatment gap in mental health care</article-title>. <source>Bull World Health Organ</source>
<volume>82</volume>: <fpage>858</fpage>–<lpage>866</lpage> Available: <ext-link ext-link-type="uri" xlink:href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2623050&amp;tool=pmcentrez&amp;rendertype=abstract">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2623050&amp;tool=pmcentrez&amp;rendertype=abstract</ext-link>.<pub-id pub-id-type="pmid">15640922</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0100773-Valderhaug1">
                <label>17</label>
                <mixed-citation publication-type="other">Valderhaug R, Götestam K, Larsson B (2004) Clinicians’ views on management of obsessive-compulsive disorders in children and adolescents. Nord J Psychiatry 58: 125–132. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/15204218">http://www.ncbi.nlm.nih.gov/pubmed/15204218</ext-link> Accessed 30 May 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Goodwin1">
                <label>18</label>
                <mixed-citation publication-type="other">Goodwin R, Koenen KC, Hellman F, Guardino M, Struening E (2002) Helpseeking and access to mental health treatment for obsessive-compulsive disorder. Acta Psychiatr Scand 106: 143–149. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/12121213">http://www.ncbi.nlm.nih.gov/pubmed/12121213</ext-link> Accessed 23 February 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Hedman1">
                <label>19</label>
                <mixed-citation publication-type="other">Hedman E, Ljótsson B, Lindefors N (2012) Cognitive behavior therapy via the Internet: a systematic review of applications, clinical efficacy and cost-effectiveness. Expert Rev Pharmacoecon Outcomes Res 12: 745–764. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/23252357">http://www.ncbi.nlm.nih.gov/pubmed/23252357</ext-link> Accessed 15 March 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Andersson1">
                <label>20</label>
                <mixed-citation publication-type="other">Andersson G, Bergström J, Holländare F, Carlbring P, Kaldo V, <etal>et al</etal>. (2005) Internet-based self-help for depression: randomised controlled trial. Br J psychiatry 187: 456–461. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/16260822">http://www.ncbi.nlm.nih.gov/pubmed/16260822</ext-link> Accessed 26 July 2011.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Hedman2">
                <label>21</label>
                <mixed-citation publication-type="other">Hedman E, Andersson G, Ljótsson B, Andersson E, Rück C, <etal>et al</etal>. (2011) Internet-based cognitive behavior therapy vs. cognitive behavioral group therapy for social anxiety disorder: a randomized controlled non-inferiority trial. PLoS One 6: e18001. Available: <ext-link ext-link-type="uri" xlink:href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3070741&amp;tool=pmcentrez&amp;rendertype=abstract">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3070741&amp;tool=pmcentrez&amp;rendertype=abstract</ext-link> Accessed 17 June 2011.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Bergstrm1">
                <label>22</label>
                <mixed-citation publication-type="other">Bergström J, Andersson G, Ljótsson B, Rück C, Andréewitch S, <etal>et al</etal>. (2010) Internet-versus group-administered cognitive behaviour therapy for panic disorder in a psychiatric setting: a randomised trial. BMC Psychiatry 10: 54. Available: <ext-link ext-link-type="uri" xlink:href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2910662&amp;tool=pmcentrez&amp;rendertype=abstract">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2910662&amp;tool=pmcentrez&amp;rendertype=abstract</ext-link> Accessed 23 February 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Andersson2">
                <label>23</label>
                <mixed-citation publication-type="other">Andersson E, Ljotsson B, Hedman E, Kaldo V, Paxling B, <etal>et al</etal>. (2011) Internet-based cognitive behavior therapy for obsessive compulsive disorder: A pilot study. BMC Psychiatry 11: 125. Available: <ext-link ext-link-type="uri" xlink:href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3163522&amp;tool=pmcentrez&amp;rendertype=abstract">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3163522&amp;tool=pmcentrez&amp;rendertype=abstract</ext-link> Accessed 17 August 2011.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Andersson3">
                <label>24</label>
                <mixed-citation publication-type="other">Andersson E, Enander J, Andrén P, Hedman E, Ljótsson B, <etal>et al</etal>. (2012) Internet-based cognitive behaviour therapy for obsessive-compulsive disorder: a randomized controlled trial. Psychol Med 42: 2193–2203. Available: <ext-link ext-link-type="uri" xlink:href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3435873&amp;tool=pmcentrez&amp;rendertype=abstract">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3435873&amp;tool=pmcentrez&amp;rendertype=abstract</ext-link> Accessed 23 February 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Wootton1">
                <label>25</label>
                <mixed-citation publication-type="other">Wootton BM, Titov N, Dear BF, Spence J, Andrews G, <etal>et al</etal>. (2011) An Internet administered treatment program for obsessive-compulsive disorder: a feasibility study. J Anxiety Disord 25: 1102–1107. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/21899983">http://www.ncbi.nlm.nih.gov/pubmed/21899983</ext-link> Accessed 11 March 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Wootton2">
                <label>26</label>
                <mixed-citation publication-type="other">Wootton BM, Dear BF, Johnston L, Terides MD, Titov N (2013) Remote treatment of obsessive-compulsive disorder: A randomized controlled trial. J Obsessive Compuls Relat Disord 2: 375–384. Available: <ext-link ext-link-type="uri" xlink:href="http://www.sciencedirect.com/science/article/pii/S2211364913000511">http://www.sciencedirect.com/science/article/pii/S2211364913000511</ext-link> Accessed 22 November 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Findahl1">
                <label>27</label>
                <mixed-citation publication-type="other">Findahl O (2012) Swedes and the Internet 2012. Stockholm:.se, internetstatistik.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Richardson1">
                <label>28</label>
                <mixed-citation publication-type="other">Richardson T, Stallard P, Velleman S (2010) Computerised cognitive behavioural therapy for the prevention and treatment of depression and anxiety in children and adolescents: a systematic review. Clin Child Fam Psychol Rev 13: 275–290. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/20532980">http://www.ncbi.nlm.nih.gov/pubmed/20532980</ext-link> Accessed 2 November 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Vigerland1">
                <label>29</label>
                <mixed-citation publication-type="other">Vigerland S, Thulin U, Ljótsson B, Svirsky L, Ost L-G, <etal>et al</etal>. (2013) Internet-Delivered CBT for Children with Specific Phobia: A Pilot Study. Cogn Behav Ther 42: 303–314. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/24245708">http://www.ncbi.nlm.nih.gov/pubmed/24245708</ext-link> Accessed 29 November 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Spence1">
                <label>30</label>
                <mixed-citation publication-type="other">Spence SH, Donovan CL, March S, Gamble A, Anderson RE, <etal>et al</etal>. (2011) A randomized controlled trial of online versus clinic-based CBT for adolescent anxiety. J Consult Clin Psychol 79: 629–642. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/21744945">http://www.ncbi.nlm.nih.gov/pubmed/21744945</ext-link> Accessed 25 October 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-March1">
                <label>31</label>
                <mixed-citation publication-type="other">March S, Spence SH, Donovan CL (2009) The efficacy of an internet-based cognitive-behavioral therapy intervention for child anxiety disorders. J Pediatr Psychol 34: 474–487. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/18794187">http://www.ncbi.nlm.nih.gov/pubmed/18794187</ext-link> Accessed 18 November 2011.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Shafran1">
                <label>32</label>
                <mixed-citation publication-type="other">Shafran R, Frampton I, Heyman I, Reynolds M, Teachman B, <etal>et al</etal>. (2003) The preliminary development of a new self-report measure for OCD in young people. J Adolesc 26: 137–142. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/12550826">http://www.ncbi.nlm.nih.gov/pubmed/12550826</ext-link> Accessed 8 October 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Piacentini2">
                <label>33</label>
                <mixed-citation publication-type="other">Piacentini J, Peris TS, Bergman RL, Chang S, Jaffer M (2007) Functional impairment in childhood OCD: development and psychometrics properties of the Child Obsessive-Compulsive Impact Scale-Revised (COIS-R). J Clin Child Adolesc Psychol 36: 645–653. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/18088221">http://www.ncbi.nlm.nih.gov/pubmed/18088221</ext-link> Accessed 23 February 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-National1">
                <label>34</label>
                <mixed-citation publication-type="journal"><collab>National Institute of Mental Health</collab> (<year>1985</year>) <article-title>Rating scales and assessment instruments for use in pediatric psychopharmacology research</article-title>. <source>Psychopharmacol Bull</source>
<volume>21</volume>: <fpage>839</fpage>–<lpage>843</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Guy1">
                <label>35</label>
                <mixed-citation publication-type="other">Guy W (1976) Assessment manual for psychopharmacology, revised. Washington DC: US Government Printing Office.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Shaffer1">
                <label>36</label>
                <mixed-citation publication-type="other">Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, <etal>et al</etal>. (1983) A children’s global assessment scale (CGAS). Arch Gen Psychiatry 40: 1228–1231. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/6639293">http://www.ncbi.nlm.nih.gov/pubmed/6639293</ext-link> Accessed 23 February 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Spence2">
                <label>37</label>
                <mixed-citation publication-type="other">Spence SH (1998) A measure of anxiety symptoms among children. Behav Res Ther 36: 545–566. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/9648330">http://www.ncbi.nlm.nih.gov/pubmed/9648330</ext-link> Accessed 23 February 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Kovacs1">
                <label>38</label>
                <mixed-citation publication-type="other">Kovacs M (1985) The Children’s Depression, Inventory (CDI). Psychopharmacol Bull 21: 995–998. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/4089116">http://www.ncbi.nlm.nih.gov/pubmed/4089116</ext-link> Accessed 23 February 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Goodman1">
                <label>39</label>
                <mixed-citation publication-type="other">Goodman R (1997) The Strengths and Difficulties Questionnaire: a research note. J Child Psychol Psychiatry 38: 581–586. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/9255702">http://www.ncbi.nlm.nih.gov/pubmed/9255702</ext-link> Accessed 8 October 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Flessner1">
                <label>40</label>
                <mixed-citation publication-type="other">Flessner CA, Sapyta J, Garcia A, Freeman JB, Franklin ME, <etal>et al</etal>. (2009) Examining the Psychometric Properties of the Family Accommodation Scale-Parent-Report (FAS-PR). J Psychopathol Behav Assess 31: 38–46. Available: <ext-link ext-link-type="uri" xlink:href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3131184&amp;tool=pmcentrez&amp;rendertype=abstract">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3131184&amp;tool=pmcentrez&amp;rendertype=abstract</ext-link> Accessed 24 August 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Hedman3">
                <label>41</label>
                <mixed-citation publication-type="other">Hedman E, Ljótsson B, Rück C, Furmark T, Carlbring P, <etal>et al</etal>. (2010) Internet administration of self-report measures commonly used in research on social anxiety disorder: A psychometric evaluation. Comput Human Behav 26: 736–740. Available: <ext-link ext-link-type="uri" xlink:href="http://apps.webofknowledge.com.proxy.kib.ki.se/full_record.do?product=WOS&amp;search_mode=OneClickSearch&amp;qid=7&amp;SID=U2rNEuf9xwmNh3jOxQb&amp;page=3&amp;doc=25">http://apps.webofknowledge.com.proxy.kib.ki.se/full_record.do?product=WOS&amp;search_mode=OneClickSearch&amp;qid=7&amp;SID=U2rNEuf9xwmNh3jOxQb&amp;page=3&amp;doc=25</ext-link> Accessed 2 November 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-SheehanD1">
                <label>42</label>
                <mixed-citation publication-type="other">Sheehan D V, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, <etal>et al</etal>. (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl 2: 22–33; quiz 34–57. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/9881538">http://www.ncbi.nlm.nih.gov/pubmed/9881538</ext-link> Accessed 23 October 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Shrout1">
                <label>43</label>
                <mixed-citation publication-type="journal"><name><surname>Shrout</surname><given-names>PE</given-names></name>, <name><surname>Fleiss</surname><given-names>JL</given-names></name> (<year>1979</year>) <article-title>Intraclass correlations: Uses in assessing rater reliability</article-title>. <source>Psychol Bull</source>
<volume>86</volume>: <fpage>420</fpage>–<lpage>428</lpage>
<pub-id pub-id-type="doi">10.1037/0033-2909.86.2.420</pub-id>
<pub-id pub-id-type="pmid">18839484</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0100773-Barrett1">
                <label>44</label>
                <mixed-citation publication-type="other">Barrett P, Healy-Farrell L, March JS (2004) Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry 43: 46–62. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/14691360">http://www.ncbi.nlm.nih.gov/pubmed/14691360</ext-link> Accessed 3 March 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Williams1">
                <label>45</label>
                <mixed-citation publication-type="other">Williams TI, Salkovskis PM, Forrester L, Turner S, White H, <etal>et al</etal>. (2009) A randomised controlled trial of cognitive behavioural treatment for obsessive compulsive disorder in children and adolescents. Eur Child Adolesc Psychiatry 19: 449–456. Available: <ext-link ext-link-type="uri" xlink:href="http://www.springerlink.com/index/10.1007/s00787-009-0077-9">http://www.springerlink.com/index/10.1007/s00787-009-0077-9</ext-link> Accessed 6 May 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Bolton1">
                <label>46</label>
                <mixed-citation publication-type="other">Bolton D, Perrin S (2008) Evaluation of exposure with response-prevention for obsessive compulsive disorder in childhood and adolescence. J Behav Ther Exp Psychiatry 39: 11–22. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/17207457">http://www.ncbi.nlm.nih.gov/pubmed/17207457</ext-link> Accessed 10 May 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Piacentini3">
                <label>47</label>
                <mixed-citation publication-type="other">Piacentini J, Bergman RL, Chang S, Langley A, Peris T, <etal>et al</etal>. (2011) Controlled comparison of family cognitive behavioral therapy and psychoeducation/relaxation training for child obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 50: 1149–1161. Available: <ext-link ext-link-type="uri" xlink:href="http://www.jaacap.com/article/S0890-8567(11)00690-3/abstract">http://www.jaacap.com/article/S0890-8567(11)00690-3/abstract</ext-link> Accessed 9 August 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-The1">
                <label>48</label>
                <mixed-citation publication-type="other">The Pediatric OCD Treatment Study (POTS) Team (2004) Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 292: 1969–1976. Available: <ext-link ext-link-type="uri" xlink:href="http://jama.ama-assn.org/cgi/content/abstract/292/16/1969">http://jama.ama-assn.org/cgi/content/abstract/292/16/1969</ext-link> Accessed 17 October 2011.</mixed-citation>
              </ref>
              <ref id="pone.0100773-March2">
                <label>49</label>
                <mixed-citation publication-type="other">March JS, Mulle K, Herbel B (1994) Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: an open trial of a new protocol-driven treatment package. J Am Acad Child Adolesc Psychiatry 33: 333–341. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/8169177">http://www.ncbi.nlm.nih.gov/pubmed/8169177</ext-link> Accessed 10 May 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Ivarsson1">
                <label>50</label>
                <mixed-citation publication-type="other">Ivarsson T, Thomsen PH, Dahl K, Valderhaug R, Weidle B, <etal>et al</etal>. (2010) The Rationale and Some Features of the Nordic Long-Term OCD Treatment Study (NordLOTS) in Childhood and Adolescence. Child Youth Care Forum 39: 91–99. Available: <ext-link ext-link-type="uri" xlink:href="http://www.springerlink.com/index/10.1007/s10566-010-9097-3">http://www.springerlink.com/index/10.1007/s10566-010-9097-3</ext-link> Accessed 7 May 2012.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Rubin1">
                <label>51</label>
                <mixed-citation publication-type="other">Rubin DB, editor (1987) Multiple Imputation for Nonresponse in Surveys. Hoboken, NJ, USA: John Wiley &amp; Sons, Inc. Available: <ext-link ext-link-type="uri" xlink:href="http://doi.wiley.com/10.1002/9780470316696">http://doi.wiley.com/10.1002/9780470316696</ext-link> Accessed 1 November 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Farris1">
                <label>52</label>
                <mixed-citation publication-type="other">Farris SG, McLean CP, Van Meter PE, Simpson HB, Foa EB (2013) Treatment response, symptom remission, and wellness in obsessive-compulsive disorder. J Clin Psychiatry 74: 685–690. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/23945445">http://www.ncbi.nlm.nih.gov/pubmed/23945445</ext-link> Accessed 16 November 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Lewin1">
                <label>53</label>
                <mixed-citation publication-type="other">Lewin AB, Peris TS, De Nadai AS, McCracken JT, Piacentini J (2012) Agreement Between Therapists, Parents, Patients, and Independent Evaluators on Clinical Improvement in Pediatric Obsessive-Compulsive Disorder. J Consult Clin Psychol 80: 1103–1107. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/22963592">http://www.ncbi.nlm.nih.gov/pubmed/22963592</ext-link> Accessed 21 May 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Skoog1">
                <label>54</label>
                <mixed-citation publication-type="other">Skoog G, Skoog I (1999) A 40-year follow-up of patients with obsessive-compulsive disorder [see commetns]. Arch Gen Psychiatry 56: 121–127. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/10025435">http://www.ncbi.nlm.nih.gov/pubmed/10025435</ext-link> Accessed 22 November 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Visser1">
                <label>55</label>
                <mixed-citation publication-type="other">Visser HA, van Oppen P, van Megen HJ, Eikelenboom M, van Balkom AJ (2013) Obsessive-compulsive disorder; chronic versus non-chronic symptoms. J Affect Disord. Available: <ext-link ext-link-type="uri" xlink:href="http://www.sciencedirect.com/science/article/pii/S0165032713006782">http://www.sciencedirect.com/science/article/pii/S0165032713006782</ext-link> Accessed 16 November 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-MataixCols1">
                <label>56</label>
                <mixed-citation publication-type="other">Mataix-Cols D, Marks I (2006) Self-help for obsessive-compulsive disorder: How much therapist contact is necessary? Clin Neuropsychiatry 3: 404–409. Available: <ext-link ext-link-type="uri" xlink:href="http://www.clinicalneuropsychiatry.org/pdf/mataix.pdf">http://www.clinicalneuropsychiatry.org/pdf/mataix.pdf</ext-link> Accessed 30 November 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Kenwright1">
                <label>57</label>
                <mixed-citation publication-type="other">Kenwright M, Marks I, Graham C, Franses A, Mataix-Cols D (2005) Brief scheduled phone support from a clinician to enhance computer-aided self-help for obsessive-compulsive disorder: randomized controlled trial. J Clin Psychol 61: 1499–1508. Available: <ext-link ext-link-type="uri" xlink:href="http://apps.webofknowledge.com.proxy.kib.ki.se/full_record.do?product=UA&amp;search_mode=GeneralSearch&amp;qid=1&amp;SID=S1G4vMOWJNmQsLUN8F5&amp;page=1&amp;doc=1">http://apps.webofknowledge.com.proxy.kib.ki.se/full_record.do?product=UA&amp;search_mode=GeneralSearch&amp;qid=1&amp;SID=S1G4vMOWJNmQsLUN8F5&amp;page=1&amp;doc=1</ext-link> Accessed 30 November 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Simpson1">
                <label>58</label>
                <mixed-citation publication-type="other">Simpson HB, Maher MJ, Wang Y, Bao Y, Foa EB, <etal>et al</etal>. (2011) Patient adherence predicts outcome from cognitive behavioral therapy in obsessive-compulsive disorder. J Consult Clin Psychol 79: 247–252. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/21355639">http://www.ncbi.nlm.nih.gov/pubmed/21355639</ext-link> Accessed 15 August 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Donker1">
                <label>59</label>
                <mixed-citation publication-type="other">Donker T, Petrie K, Proudfoot J, Clarke J, Birch M-R, <etal>et al</etal>. (2013) Smartphones for Smarter Delivery of Mental Health Programs: A Systematic Review. J Med Internet Res 15: e247. Available: <ext-link ext-link-type="uri" xlink:href="http://www.jmir.org/2013/11/e247/Accessed">http://www.jmir.org/2013/11/e247/Accessed</ext-link> 19 November 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Comer1">
                <label>60</label>
                <mixed-citation publication-type="other">Comer JS, Furr JM, Cooper-Vince CE, Kerns CE, Chan PT, <etal>et al</etal>. (2013) Internet-Delivered, Family-Based Treatment for Early-Onset OCD: A Preliminary Case Series. J Clin Child Adolesc Psychol: 1–14. Available: <pub-id pub-id-type="doi">10.1080/15374416.2013.855127</pub-id> Accessed 7 December 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Storch1">
                <label>61</label>
                <mixed-citation publication-type="other">Storch EA, Caporino NE, Morgan JR, Lewin AB, Rojas A, <etal>et al</etal>. (2011) Preliminary investigation of web-camera delivered cognitive-behavioral therapy for youth with obsessive-compulsive disorder. Psychiatry Res 189: 407–412. Available: <ext-link ext-link-type="uri" xlink:href="http://www.sciencedirect.com/science/article/pii/S0165178111004446">http://www.sciencedirect.com/science/article/pii/S0165178111004446</ext-link> Accessed 7 December 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-MataixCols2">
                <label>62</label>
                <mixed-citation publication-type="other">Mataix-Cols D, Marks IM (2006) Self-help with minimal therapist contact for obsessive-compulsive disorder: a review. Eur Psychiatry 21: 75–80. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/16360307">http://www.ncbi.nlm.nih.gov/pubmed/16360307</ext-link> Accessed 14 November 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Salloum1">
                <label>63</label>
                <mixed-citation publication-type="other">Salloum A (2010) Minimal therapist-assisted cognitive–behavioral therapy interventions in stepped care for childhood anxiety. Prof Psychol Res Pract 41: 41–47. Available: <ext-link ext-link-type="uri" xlink:href="http://apps.webofknowledge.com.proxy.kib.ki.se/full_record.do?product=UA&amp;search_mode=CitingArticles&amp;qid=22&amp;SID=S1G4vMOWJNmQsLUN8F5&amp;page=2&amp;doc=16">http://apps.webofknowledge.com.proxy.kib.ki.se/full_record.do?product=UA&amp;search_mode=CitingArticles&amp;qid=22&amp;SID=S1G4vMOWJNmQsLUN8F5&amp;page=2&amp;doc=16</ext-link> Accessed 30 November 2013.</mixed-citation>
              </ref>
              <ref id="pone.0100773-Timpano1">
                <label>64</label>
                <mixed-citation publication-type="other">Timpano KR, Moritz S, Hauschildt M, Wittekind CE (2011) Do it yourself? Self-help and online therapy for people with obsessive-compulsive disorder. Curr Opin Psychiatry: 1. doi:10.1097/YCO.0b013e32834abb7f.</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
